<div class="image-wrapper yf-1gfnohs" style="--aspect-ratio: 960 / 325;...
Comprehensive immunogenicity data of individualized neoantigen therapeutic vaccine (INTV) TG4050, from...
On September 30, 2025, U.S. District Judge Reed O’Connor entered final judgment following a...
The Company reported revenue of $3.0 million in...
